123 related articles for article (PubMed ID: 20676679)
1. Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma.
Tanaka T; Kitamura H; Torigoe T; Hirohashi Y; Sato E; Masumori N; Sato N; Tsukamoto T
J Cancer Res Clin Oncol; 2011 May; 137(5):789-94. PubMed ID: 20676679
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high
Miikkulainen P; Högel H; Seyednasrollah F; Rantanen K; Elo LL; Jaakkola PM
J Biol Chem; 2019 Mar; 294(10):3760-3771. PubMed ID: 30617181
[TBL] [Abstract][Full Text] [Related]
4. Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma.
Sato E; Torigoe T; Hirohashi Y; Kitamura H; Tanaka T; Honma I; Asanuma H; Harada K; Takasu H; Masumori N; Ito N; Hasegawa T; Tsukamoto T; Sato N
Clin Cancer Res; 2008 Nov; 14(21):6916-23. PubMed ID: 18980986
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells.
Place TL; Fitzgerald MP; Venkataraman S; Vorrink SU; Case AJ; Teoh ML; Domann FE
PLoS One; 2011 Jan; 6(1):e14617. PubMed ID: 21297970
[TBL] [Abstract][Full Text] [Related]
7. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer.
Su Y; Loos M; Giese N; Hines OJ; Diebold I; Görlach A; Metzen E; Pastorekova S; Friess H; Büchler P
Br J Cancer; 2010 Nov; 103(10):1571-9. PubMed ID: 20978507
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma.
Baldin AV; Grishina AN; Korolev DO; Kuznetsova EB; Golovastova MO; Kalpinskiy AS; Alekseev BY; Kaprin AD; Zinchenko DV; Savvateeva LV; Varshavsky VA; Zernii EY; Vinarov AZ; Bazhin AV; Philippov PP; Zamyatnin AA
Biochimie; 2019 Feb; 157():26-37. PubMed ID: 30389514
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.
Sato K; Tsuchiya N; Sasaki R; Shimoda N; Satoh S; Ogawa O; Kato T
Jpn J Cancer Res; 1999 Aug; 90(8):874-9. PubMed ID: 10543260
[TBL] [Abstract][Full Text] [Related]
10. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
Jaakkola PM; Rantanen K
Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
12. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.
Yi Y; Mikhaylova O; Mamedova A; Bastola P; Biesiada J; Alshaikh E; Levin L; Sheridan RM; Meller J; Czyzyk-Krzeska MF
Clin Cancer Res; 2010 Nov; 16(21):5142-52. PubMed ID: 20978146
[TBL] [Abstract][Full Text] [Related]
14. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
16. mRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma.
Kampantais S; Kotoula V; Kounatidis I; Vakalopoulos I; Gourvas V; Lymperi S; Dimitriadis G
Mol Clin Oncol; 2020 Sep; 13(3):11. PubMed ID: 32754325
[TBL] [Abstract][Full Text] [Related]
17. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation.
Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K
Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999
[TBL] [Abstract][Full Text] [Related]
18. Serum tissue factor as a biomarker for renal clear cell carcinoma.
Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
[TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.
Xu Y; Gao Q; Xue Y; Li X; Xu L; Li C; Qin Y; Fang J
J Biol Chem; 2019 Jun; 294(25):9949-9958. PubMed ID: 31092600
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2.
Nakayama K; Gazdoiu S; Abraham R; Pan ZQ; Ronai Z
Biochem J; 2007 Jan; 401(1):217-26. PubMed ID: 16958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
